DCK antibody
Quick Overview for DCK antibody (ABIN7464354)
Target
See all DCK AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Affinity purified by Protein A.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human DCK. The exact sequence is proprietary.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: A549 , H1299 , HCT116 , Neuro 2A , C8D30 , NIH-3T3 , Raw264.7 , PC-12 , Rat2 , 293T , A431 , HeLa , HepG2 , DCK-transfected 293T
Validation: Overexpression
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.01 mg/mL
-
Buffer
- PBS, No Preservative
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- DCK (Deoxycytidine Kinase (DCK))
-
Alternative Name
- deoxycytidine kinase
-
Background
- Deoxycytidine kinase,Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq]
-
Molecular Weight
- 31 kDa
-
Gene ID
- 1633
-
UniProt
- P27707
Target
-